bims-medebr Biomed News
on Metabolism of the developing brain
Issue of 2026–05–10
twenty-two papers selected by
Regina F. Fernández, Johns Hopkins University



  1. Acta Neuropathol. 2026 May 03. pii: 52. [Epub ahead of print]151(1):
      Lipofuscin is an autofluorescent material that accrues in brain tissues with age and in Neuronal Ceroid Lipofuscinosis (NCL), a neurodegenerative disease with pediatric onset. The distribution, composition, and organellar origin of lipofuscin have remained unclear despite its widespread presence in aged tissues and involvement in neurodegeneration. Here, we elucidate lipofuscin composition in mouse and human brain and assemble a reference neuroanatomical atlas of lipofuscin accumulation with age and NCL (Type 1; CLN1) progression across 425 fine brain regions. We identify a primary role of the lysosomal-mitochondrial axis in the formation of lipofuscin pathology via multimodal mass spectrometry, ultrastructural analyses, and assays of cellular and enzymatic metabolism. We find the protein and lipid composition of lipofuscin in the aged and CLN1 brain to be remarkably similar. Dissection of implicated molecular pathways reveals protein S-acylation and unsaturated lipid homeostasis as central processes involved in lipofuscin deposition during aging and CLN1. Notably, > 95% of lipofuscin resident proteins can be S-acylated and many are substrates of the enzyme PPT1, validating a seminal hypothesis that CLN1 lipofuscin contains these lipid-modified proteins. Further, we discover deficient de-S-acylation is correlated with lipofuscin load in healthy aging, as the specific de-S-acylation enzyme activity of PPT1 is found to decline with advancing age. Finally, we identify lipid metabolite biomarkers of lipofuscin, including long-chain polyunsaturated fatty acids, bis(monoacylglycerol)phosphate (BMP), and oxidized phosphatidylethanolamine (OxPE) lipid species. Overall, we provide a comprehensive redefinition of lipofuscin neuropathology and a resource for studying aging, lysosomal storage disorders, and neurodegeneration.
    Keywords:   CLN1 ; Aging; Autofluorescence; Lipid homeostasis; Lipofuscin; Lysosomal storage disorder; Mitochondria-lysosome axis; Neurodegeneration; Neuronal Ceroid Lipofuscinosis; Palmitoyl protein thioesterase 1; S-acylation
    DOI:  https://doi.org/10.1007/s00401-026-03012-7
  2. Ageing Res Rev. 2026 May 06. pii: S1568-1637(26)00151-0. [Epub ahead of print] 103159
      Lipid homeostasis is essential for preserving the structural integrity and functional capacity of the brain. A diverse array of lipids, including cholesterol, phospholipids, and sphingolipids, has been identified as playing pivotal roles. Dysregulation of lipid metabolism is increasingly recognized as a central pathological mechanism in neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Huntington's Disease, and Cerebrotendinous Xanthomatosis, though much of the existing evidence comes from associative studies, and causal relationships still need to be further validated through interventional studies. Here we systematically review the metabolic pathways and regulatory networks of major brain lipids, with a focus on delineating disease-specific alterations and summarizing emerging therapeutic strategies targeting lipid metabolism. These strategies encompass the modulation of cholesterol homeostasis, sphingolipid metabolism, phospholipid signaling, and fatty acid oxidation, alongside approaches that enhance lipid clearance and neural repair. Preclinical advances and ongoing clinical trials underscore the translational potential of lipid-targeted interventions. In conclusion, we emphasize the potential of lipid metabolism as a promising avenue for developing novel treatments, offering insights to guide future research and therapeutic innovation in neurodegeneration.
    Keywords:  Alzheimer's disease; Lipid metabolism; Mitochondrial dysfunction; Neurodegeneration; Neuroinflammation; Parkinson's disease
    DOI:  https://doi.org/10.1016/j.arr.2026.103159
  3. Biomolecules. 2026 Apr 01. pii: 526. [Epub ahead of print]16(4):
      A novel subtype of microglia, lipid droplet accumulation microglia (LDAMs), has been identified in the aged brain, which is characterized by sustained inflammation and senescent-like phenotypes. LDAMs are deeply involved in promoting brain aging as well as the pathogenesis of multiple neurodegenerative diseases. Cocaine can alter brain lipidomic profiles, induce microglial activation, and accelerate brain aging. This suggests that cocaine might affect microglial lipid metabolism, which ultimately aggravates aging-related neurological disorders in people with addictions. In this study, we explored the effects of cocaine on microglial lipid metabolism. Our results showed that chronic cocaine administration altered brain lipid profiles and increased LDAM formation in vivo. The increase in LDAMs was accompanied by the upregulation of the senescent marker p53 in the brain. Cocaine also increased lipid droplet (LD) formation in BV2 microglia and primary microglia in vitro. A mechanism study revealed that cocaine increased the levels of SREBP1/2, HMGCR, DGAT1, and FASN, which are critical for lipid synthesis. Overall, our findings demonstrate that cocaine increases LDAM formation in vitro and in vivo. These results indicate that targeting microglia lipid metabolism might be a promising therapeutic approach to mitigate aging-related neurological syndromes in people with cocaine addictions.
    Keywords:  cocaine; lipid droplets; microglia; neuroinflammation; senescence
    DOI:  https://doi.org/10.3390/biom16040526
  4. J Biol Chem. 2026 May 06. pii: S0021-9258(26)01975-7. [Epub ahead of print] 113103
      Adrenoleukodystrophy (ALD or X-ALD) is a rare devastating neurological disease caused by mutations in the ATP binding cassette D1 (ABCD1) gene, product of which is involved in the transport of Very Long Chain Fatty Acids (VLCFAs) into peroxisome for degradation by β-oxidation. Deficiency in ABCD1 results in VLCFAs accumulation in many tissues, including the brain and spinal cord. Elevated VLCFA levels, specifically C26:0, are consistent biochemical markers of ALD and are implicated in the ALD pathogenesis. ALD disease is manifested by multiple phenotypes: the most severe cerebral disease (cerebral ALD, cALD), adrenomyeloneuropathy (AMN) and adrenal insufficiency (Addison disease). VLCFA's accumulation is a hallmark of all ALD phenotypes, and reduction/normalization of VLCFA's level is an attractive approach for the treatment of all ALD manifestations. VLCFAs synthesis involves enzymes from Elongase of Very Long chain fatty acids (ELOVL) enzyme family with ELOVL1 being a rate-limiting enzyme in C26:0 synthesis, making ELOVL1 an attractive target for medical intervention in ALD via Substrate Reduction Therapy (SRT). In this paper, we describe the in vitro assays established in support of medicinal chemistry efforts to develop small molecule ELOVL1 inhibitors for ALD. Notably, we developed novel breakthrough in vitro methods to monitor enzymatic and cellular ELOVL1 activity that enabled high-throughput screening (HTS) of Sanofi library collections. We successfully identified CNS active small molecule ELOVL1 inhibitors shown to be efficacious in reduction of C26:0 VLCFA levels in cells and multiple tissues including brain and spinal cord in animal models.
    DOI:  https://doi.org/10.1016/j.jbc.2026.113103
  5. J Neuroinflammation. 2026 May 04.
      Given the prevalence of metabolic perturbations in a variety of neurological and neurodegenerative diseases, understanding and monitoring brain metabolism is a key step in our advancement of therapies. The details of the citric acid cycle were established at the beginning of the last century but only recently have its metabolic intermediates been observed in vivo in the brain. In this study, we employed orthogonal analyses to investigate metabolic alterations in response to acute neuroinflammation in vivo, demonstrating a multi-technique approach that could be used for future studies.Hyperpolarized [1-13C] pyruvate spectroscopy revealed an early decline in pyruvate metabolism via pyruvate dehydrogenase (PDH), leading to reduced 13C-bicarbonate formation. This metabolic disruption occurred despite the absence of structural or perfusion changes on conventional MRI. Further analysis of polar metabolites in the ipsilateral hemisphere confirmed ongoing inflammatory processes. These findings highlight the potential of this dual technique approach to inform upon metabolic changes due to neuroinflammation.Combining methods to probe metabolism in invasive (metabolomics) and non-invasive (hyperpolarized MRI) manners, this represents a promising translational approach for real-time metabolic assessments in an area of the body, the brain, where studying processes such as metabolism has traditionally been challenging. This study has demonstrated the approach to monitor changes in metabolism in response to inflammation in the brain.
    Keywords:  Hyperpolarized; Imaging; Metabolism; Neuroinflammation; Pyruvate
    DOI:  https://doi.org/10.1186/s12974-026-03839-7
  6. iScience. 2026 May 15. 29(5): 115702
      Neurons depend on glucose to sustain their high energetic demands; yet, ketone bodies can serve as alternative substrates during ketogenic states. Here, we examined how β-hydroxybutyrate reshapes metabolism and function in human iPSC-derived neurons. Neurons generated from neuroepithelial stem cells were cultured in glucose-rich media or low-glucose media supplemented with β-hydroxybutyrate. We developed an electrochemical biosensor for ketone detection and validated its performance by cyclic voltammetry and amperometry, achieving linear sensitivity in the 0.01 to 0.1 mM range. Metabolic changes for neurons were assessed through glucose consumption and lactate production, and transcriptional profiling revealed reduced expression of selected metabolic and ketone-associated genes under ketone supplementation. Calcium imaging further showed lower firing rates in ketone exposed neurons compared with glucose conditions. Together, these results demonstrate how alternative energy substrates modulate neuronal metabolism and excitability, providing a framework to evaluate metabolic interventions for neurological disorders.
    Keywords:  Analytical chemistry; Bioengineering; Cell biology
    DOI:  https://doi.org/10.1016/j.isci.2026.115702
  7. Front Cell Dev Biol. 2026 ;14 1783696
       Introduction: Lipoproteins are the main lipid carriers in extracellular fluids and mediate the exchange of hydrophobic molecules between cells and their environment in animals, including cholesterol. Lipoprotein metabolism has been implicated in the regulation of angiogenesis, suggesting that cholesterol is important for this process, but a direct role for this lipid has not been unequivocally demonstrated, particularly in the central nervous system (CNS).
    Methods: Here, we used genetic and pharmacological models to address this issue in different models of CNS angiogenesis.
    Results: We show that inactivation of ABCA1, one of the main cholesterol efflux pumps, leads to altered brain vascularization and a longer angiogenic window, while inactivation of the bidirectional cholesterol transporter SR-B1 has no effect. These functional changes are accompanied by consistent transcriptomic changes in genes involved in cholesterol synthesis and angiogenesis. In support of the role of cholesterol, experimental reduction of this lipid in cultured brain endothelial cells leads to a transcriptomic signature showing the opposite direction in those genes.
    Discussion: These studies support a role for ABCA1 and cholesterol in regulating a trascriptional program governing angiogenesis in the brain.
    Keywords:  ABCA1; angiogenesis; blood-brain barrier; brain; cholesterol
    DOI:  https://doi.org/10.3389/fcell.2026.1783696
  8. bioRxiv. 2026 Apr 21. pii: 2026.04.16.718987. [Epub ahead of print]
      Extracellular vesicles (EVs) mediate intercellular transfer of lipids, proteins, and nucleic acids between nearly all cell types. We previously showed that astrocyte-derived EVs modulate neuronal mitochondria in vitro , but whether endogenous astrocytic EVs are trafficked to neuronal mitochondria in vivo remained unknown. To address this, we generated an EV reporter mouse, Aldh1l1-Cre; CD9-tGFP fl/fl , in which astrocyte-secreted EVs are labeled with a CD9-turboGFP fusion protein (CD9-tGFP). Astrocyte-specific expression of CD9-tGFP was verified in brain tissue and isolated EVs, comprising 13.2 ± 1.6% of total brain EVs. In primary glial cultures, CD9-tGFP was restricted to astrocytes, localizing to vesicular compartments and cell protrusions (filopodia and cilia), with 89.3 ± 2.2% of astrocyte-derived EVs carrying the label. These EVs were enriched with the sphingolipid ceramide, consistent with its co-distribution with CD9-tGFP in astrocytic cell protrusions. In the cortex, hippocampus, and cerebellum, CD9-tGFP was predominantly detected in astrocytic processes co-labeled with GLAST1 and GFAP, forming contacts with laminin-positive capillaries and parvalbumin-positive neurons. CD9-tGFP-labeled EVs were detected inside capillaries and neurons, and super-resolution STED microscopy revealed partial overlap with neuronal mitochondria. Live-cell spinning disk confocal imaging and AI-assisted proximity analysis confirmed uptake of CD9-tGFP EVs by neuronal cells and trafficking of their cargo to mitochondria in vitro . Biochemical isolation of synaptic and non-synaptic mitochondria confirmed EV-derived cargo on mitochondria in vivo , with 3-fold higher association of CD9-tGFP with synaptic than non-synaptic mitochondria. Together, these findings validate the Aldh1l1-Cre; CD9-tGFP fl/fl reporter mouse as a powerful tool for tracking astrocyte-derived EVs in vivo and provide direct evidence that their cargo is preferentially trafficked to synaptic mitochondria.
    DOI:  https://doi.org/10.64898/2026.04.16.718987
  9. FASEB Bioadv. 2026 May;8 e70113
      Apolipoprotein E4 (APOE4) is the strongest genetic risk factor for Alzheimer's disease (AD), yet it's unclear how this allele promotes disease. While factors like diet and sex may modify AD susceptibility in APOE4 carriers, the interaction between these factors is poorly understood. Here, we sought to determine if APOE4, sex, and diet interact to influence AD related outcomes in mice. Male and female APOE3 and APOE4 targeted replacement (TR) mice were fed a low-fat diet or high-fat diet from 4 to 8 months old. Serum neurodegenerative disease biomarkers, brain amyloid beta (Aβ), APOE, and tau, learning and memory, hippocampal mitochondrial function and proteomics data were collected. Serum GFAP and NfL were unaffected by APOE4, while HFD was associated with greater serum NfL and GFAP. Whole brain Aβ was significantly altered by sex, diet, and genotype. There was a main effect of genotype on levels of brain APOE with levels being lower in APOE4 mice. APOE4 TR mice also exhibited impaired learning before diet. Proteomic analysis revealed that APOE4 exerts diet- and sex-dependent effects on mitochondrial pathways. This included downregulation of pyruvate metabolism in HFD males and oxidative phosphorylation in HFD females. Basal respiration was lower in APOE4 versus APOE3 TR females. We provide novel evidence that APOE4 may drive early sex- and diet-dependent reductions in pathways that support brain mitochondrial energy metabolism.
    Keywords:  Alzheimer's disease; apolipoprotein E; learning; memory; mitochondria; neurodegeneration
    DOI:  https://doi.org/10.1096/fba.2026-00121
  10. Free Neuropathol. 2026 ;7 9
      Recent computational advances in mass spectrometry imaging (MSI) now enable unprecedented insight into organ-wide molecular composition and functional architecture. Here, we present the first high-resolution molecular-computational atlas of specific mouse brain lipids and metabolites, acquired using a NEDC matrix and negative-mode MSI, covering 123 anatomically defined regions and 191 polygonal annotations derived solely from MSI data, without auxiliary imaging. To overcome annotation ambiguity and MSI complexity, we introduced the Computational Brain Lipid Atlas (CBLA), a graph-based visual-explainability framework that generates Virtual Landscape Visualizations (VLVs) of specific lipid distributions across brain substructures. The CBLA integrates dimensionality reduction and ensembles of supervised models to (i) refine annotations, (ii) elucidate interregional relationships, (iii) interpret model behavior, and (iv) formulate biologically testable hypotheses. The CBLA revealed novel lipid distribution patterns, functional integrations, anatomical connections - the brain's telephone cables, and region-specific disease signatures - index lipids, including disease networks in the basal ganglia. It further identified index lipids that trace extrapyramidal nuclei and their cortical-brainstem connections, highlighting network-level molecular organization. A new algorithm decomposes annotated regions into precise mass-to-charge (m/z) features and resolves high-resolution m/z values from MSI data, m/z producing a comprehensive high-resolution brain map. It can be applied to any MS measurements, including metabolites, lipids, and peptides. This resource underpins downstream studies, as exemplified here by characterizing the molecular lipid composition of Aβ plaques in APP and ABCA7 transgenic mice, their spatial arrangement, and their connections with surrounding tissue. For the first time, our data suggest that GM3 ganglioside accumulation in cortical amyloid plaques may originate from hippocampal structures, consistent with longstanding evidence of disrupted hippocampo-cortical connectivity; a similar origin may also apply to plaque-associated Aβ signals in the cortex. More broadly, several selected m/z signals showed putative anatomical origins in specific brain subregions. Together, these findings establish MSI-ATLAS as a general framework for mapping brain organization and disease-related molecular networks directly from MSI data.
    Keywords:  ABCA7; Alzheimer's disease; Brain atlas; Data visualization; Dimensionality reduction; Explainability; Explainable machine learning; GM3; Index lipids; Lipidomics; MSI-ATLAS; MSI-VISUAL; Machine learning; Mass spectrometry imaging
    DOI:  https://doi.org/10.17879/freeneuropathology-2026-9413
  11. Theranostics. 2026 ;16(11): 5926-5950
      The apolipoprotein E (APOE) ε4 allele is the primary genetic driver of late-onset Alzheimer's disease (AD), a complex neurodegenerative disorder characterized by the interplay of amyloid-β (Aβ) accumulation, tau pathology, neuroinflammation, and lipid metabolism dysfunction. Emerging evidence suggests that these pathological hallmarks are fundamentally linked to deficits in neuroplasticity and the continuous turnover of synapses. A growing body of evidence highlights APOE lipidation, a process by which APOE is loaded with lipids via cellular transporters such as ABCA1, as a key determinant of APOE function and toxicity. While lipidated APOE2 and APOE3 facilitate cholesterol transport and Aβ clearance, lipid-poor APOE4 is associated with impaired receptor-mediated clearance of Aβ, disrupted microglial function, increased neuroinflammation, and synaptic deficits. Furthermore, APOE lipidation status differentially influences tau pathology, potentially linking cholesterol dysregulation to tau hyperphosphorylation and aggregation. Here, we systematically examine the mechanistic role of APOE lipidation in AD pathogenesis, focusing on its effects on Aβ and tau pathology. We also discuss how dysregulation of APOE lipidation may serve as a central molecular mechanism connecting APOE4 to multiple pathological hallmarks of AD. This review examines how APOE lipidation is involved in amyloid-related and tau pathology in AD.
    Keywords:  APOE; Alzheimer's disease; Aβ pathology; Tau pathology; lipidation
    DOI:  https://doi.org/10.7150/thno.131926
  12. NMR Biomed. 2026 Jun;39(6): e70295
      Over the past 15 years, the number of studies employing functional magnetic resonance spectroscopy (fMRS) has tripled, driven in part by improvements in scanner performance and a growing interest in the investigation of metabolic dynamics associated with the modulation of brain activity. Higher static magnetic fields, enhancements in gradient strength and stability, more sensitive RF coil designs, and refinements in quantification approaches have considerably increased spectral quality and temporal resolution. Together, these developments have further strengthened the unique ability of fMRS to monitor in vivo metabolic changes. Given its role in oxidative metabolism and its relevance in brain energetics, lactate (Lac) is one of the most studied metabolites, following the most important excitatory (glutamate [Glu]) and inhibitory (GABA) neurotransmitters. This meta-analysis aims to obtain an estimate of mean Lac changes in the healthy human brain during a task, by grouping together the papers published to date according to magnetic field strength, spectroscopic sequence echo time, and task design. Across all included studies, an increase in Lac concentration during stimulation is reported by all the papers included in this meta-analysis, with a statistically significant increase between the stimulation and rest periods of 22%. Studies using visual stimuli reported a significantly higher increase of Lac compared to studies employing motor or cognitive tasks. No significant differences emerged between studies at different magnetic field strengths or echo times. This meta-analysis, however, revealed a substantial methodological heterogeneity, highlighting the need for greater standardization in fMRS methodologies.
    Keywords:  brain metabolism; fMRS; functional magnetic resonance spectroscopy; lactate
    DOI:  https://doi.org/10.1002/nbm.70295
  13. Life Metab. 2026 Jun;5(3): loag005
      The central nervous system is highly sensitive to energy supply, and the hippocampus operates under sustained metabolic load due to continuous synaptic activity and information processing. Lysosomes couple nutrient status to cellular energetics through the mechanistic target of rapamycin complex 1 (mTORC1) and the autophagy-lysosome pathway, yet their -subcellular contribution to neuronal metabolic profiles remains unclear. To address this, we established an in vivo AAV-LysoTag/Lyso-IP workflow combined with metabolomics to quantify metabolites within mouse hippocampal lysosomes. An in vitro Lyso-IP platform and immunofluorescence provided cell-based validation. Under every-other-day fasting, hippocampal lysosomes exhibited reprogramming: small-molecule substrates derived from amino acids and fatty acids accumulated; bis(monoacylglycero)phosphate was upregulated, indicating enhanced intraluminal vesicle formation and lipid degradation/sorting; -sphingolipids and cardiolipin increased, consistent with selective mitophagy. Notably, high basal lysosomal levels of malic acid and α-ketoglutarate (α-KG) suggested additional sources beyond the mitochondria. Immunofluorescence further showed lysosomal localization of isocitrate dehydrogenase and fumarate hydratase, suggesting partial residency of these enzymes. The oxoglutarate carrier (SLC25A11) signals were observed in LAMP1+ compartments, suggesting potential transmembrane exchange of α-KG and malic acid. Together, our data indicate that lysosomal tricarboxylic acid -related metabolites are maintained by three parallel routes: mitochondrial delivery to lysosomes, local production by resident enzymes, and transporter-mediated exchange. These metabolites supplement and reshape neuronal carbon flux and metabolic resilience at the subcellular level. Our findings elevate lysosomes from degradative endpoints to mobilizable metabolic hubs in the brain and provide both methodological and conceptual frameworks for neurometabolic adaptation under energy scarcity.
    Keywords:  Lyso-IP; TCA cycle; lysosome; metabolomics; mouse hippocampus
    DOI:  https://doi.org/10.1093/lifemeta/loag005
  14. bioRxiv. 2026 Apr 23. pii: 2026.04.20.719702. [Epub ahead of print]
      Traumatic brain injury (TBI) triggers complex and evolving secondary cascades that disrupt mitochondrial homeostasis and contribute to progressive neurodegeneration. Although mitochondrial impairment is a well-recognized driver of post-traumatic pathology, the spatial and temporal progression of mitochondrial dysfunction, particularly in regions distal to the injury site, remains poorly defined, and potential sex-specific responses remain understudied. Here, we performed a comprehensive mitochondrial-focused analysis in a mouse model of controlled cortical impact (CCI), quantifying mtDNA copy number (mtDNA-CN), mitochondrial gene expression, and protein markers regulating biogenesis, transcription, electron transport chain integrity, and mitophagy. Mitochondrial profiles were assessed across four brain regions (cortex at 2, 4, and 6 mm from the injury epicenter, and hippocampus) at four time points (6h, 12h, 24h, and 48h) in both female and male C57BL/6J mice. While mtDNA content exhibited only modest and region-restricted reduction, particularly near the injury core, transcriptional and protein-level changes were far more pronounced and sex-divergent. Females displayed extensive early cortical gene activation followed by widespread hippocampal suppression at 48 h across mitochondrial dynamics, OXPHOS, transcriptional regulation, and biogenesis pathways, accompanied by 48h in PGC-1α, TFAM, and NDUFS1. In contrast, males showed minimal transcriptional disruption but demonstrated delayed compensatory increases in TFAM, NDUFS1, and p62 protein levels, suggesting activation of mitochondrial maintenance and recovery programs. These spatially and temporally distinct responses reveal fundamental sex-specific vulnerabilities in mitochondrial regulation after TBI. Together, our findings provide a direction to an integrated mitochondrial landscape of early post-injury events and identifies critical windows and pathways that may support sex-specific therapeutic targeting to restore mitochondrial function after TBI.
    DOI:  https://doi.org/10.64898/2026.04.20.719702
  15. J Lipid Res. 2026 May 04. pii: S0022-2275(26)00079-9. [Epub ahead of print] 101053
      People living with HIV develop persistent neurocognitive impairment despite viral suppression through incompletely defined mechanisms. HIV-1 Tat disrupts VAPB-PTPIP51 coupling at mitochondria-associated ER membranes via PTPIP51 tyrosine phosphorylation, causing VAPB relocalization away from MAMs, a causal mechanism established in our prior work. Here, we define the downstream metabolic consequences and establish VAPB as the critical determinant of neuronal lipid pathology. Lipidomic profiling identified triglycerides as the dominant altered species, comprising polyunsaturated forms normally destined for membrane synthesis or mitochondrial oxidation, consistent with membrane catabolism rather than de novo lipogenesis. Targeted metabolomics revealed bioenergetic collapse consistent with impaired mitochondrial oxidative function. The resulting lipid imbalance, including lipid droplet accumulation, produced secondary organellar dysfunction, including Golgi dispersal and ER stress. Critically, Tat failed to induce lipid droplet accumulation in shRNA-VAPB cells, while PTPIP51 silencing had no such protective effect, establishing that VAPB relocalization is the obligate trigger. Guanosine supplementation reduced lipid droplet accumulation, suggesting a link to bioenergetic failure that warrants further investigation. In postmortem HIV-infected frontal cortex, VAPB was paradoxically elevated yet correlated with worsening dementia severity, consistent with transcriptional upregulation that cannot overcome post-translational blockade of VAPB-MAM localization. The polyunsaturated triglycerides, depleted plasmalogens, and elevated ceramides documented here closely parallel lipid signatures reported in PLWH with cerebrovascular complications, implicating Tat-driven lipid dysregulation as a candidate mechanism for the incompletely explained elevation in stroke risk in this population.
    Keywords:  HAND; HIV-1 Tat; VAPB; lipid droplets; mitochondria-ER contacts; stroke; triglycerides
    DOI:  https://doi.org/10.1016/j.jlr.2026.101053
  16. Front Psychiatry. 2026 ;17 1727711
      Psychiatric diseases are progressively recognized as disruptions in brain dynamics that can be measured using electrophysiological and metabolic indicators. Conventional EEG investigations utilizing power spectra or standard entropy metrics (sample entropy, multiscale entropy, permutation entropy) have shown diagnostic significance but are constrained in their ability to capture higher-order relationships. This work combines psychiatric ideas with sophisticated mathematical methods to discover new indicators of modified brain complexity. From an engineering standpoint, we provide entropy-doubling, an information-theoretic approach utilized for EEG signals for the first time. In contrast to conventional entropy measures, entropy-doubling assesses the evolution of informational complexity under distributional convolution, hence uncovering redundancy and structural scaling characteristics that are not discernible through existing metrics. We associate these metrics with biochemical markers, such as lactate, to investigate potential metabolic coupling of brain processes in bipolar disorder. It has the characteristics of a biphasic energy dysregulation. The aim of this study is to investigate the correlation between electrophysiological brain dynamics, as quantified by entropy doubling and Ruzsa distance measures derived from EEG signals, and lactate levels, in patients with bipolar disorder with mania-predominant polarity. According to our results, high-beta amplitude entropy provides the strongest and most consistent correlations with lactate. This combined framework of psychiatry and biomedical engineering provides a novel, interpretable pathway toward quantitative biomarkers in psychiatric research.
    Keywords:  EEG; bipolar disorder; lactate; mania predominant polarity; metabolic syndrome; mitochondrial dysfunction
    DOI:  https://doi.org/10.3389/fpsyt.2026.1727711
  17. J Neurotrauma. 2026 Apr;43(7-8): 660-679
      Traumatic brain injury (TBI) is a leading cause of acquired neurological disability in children of both sexes. Little is known about sex-dependent differences in oxidative stress and inflammatory response, two important variables in the developing brain after TBI. Using controlled cortical impact (CCI) in 17-day-old male rats to model pediatric TBI, we showed that docosahexaenoic acid (DHA) improved neurological outcomes and decreased markers of post-injury day 1 (D1) oxidative stress and D3 pro-inflammatory microglial activation. Sex affects DHA metabolism, TBI outcomes, and neuroinflammation. Whether DHA sex-dependently affects markers of oxidative stress or brain inflammation in immature pups after TBI is unknown. We hypothesized that DHA would decrease oxidative stress and increase markers of inflammation resolution after CCI in male pups only and would not affect control (CON) pups of either sex. We analyzed CD11b+ cells from rat brains at D1, D3, and D7 for inflammation-related protein expression, DHR123 oxidation as a marker of reactive oxygen species (ROS) production, and phagocytic capacity. In CCI males, DHA increased macrophage phagocytic capacity at D1 and D7. DHA abrogated increased ROS after CCI in macrophages of both sexes at D1 but at D3 decreased ROS only in males. DHA instead increased ROS in female CCI macrophages at D3 and D7. DHA decreased ROS in male D7 CCI microglia but not in females. In both sexes, DHA increased the relative abundance of CCI macrophages expressing IL-10 and CD206, proteins associated with inflammation resolution. In CON rats, DHA decreased phagocytic capacity in D3 male microglia and in D7 female macrophages. DHA increased ROS in D3 and D7 female microglia. Collectively, in males DHA was associated with increased phagocytosis and inflammation-resolving protein expression together with decreased ROS in macrophages after CCI, markers often associated with neuroprotection. In females, DHA had opposite effects on ROS in CCI macrophages. Contrary to our hypothesis, DHA affected CON microglia. We present preliminary data showing that DHA affected phospholipid abundance for some specific classes in both sexes and, in males only, for others. Our findings raise the importance of using sex-matched injured and control subjects when researching putative neurotherapeutics targeting inflammation and oxidative stress after pediatric TBI.
    Keywords:  developmental; docosahexaenoic acid; microglia; oxidative stress; phagocytosis
    DOI:  https://doi.org/10.1177/08977151251393989
  18. Res Sq. 2026 Apr 28. pii: rs.3.rs-7437638. [Epub ahead of print]
      Intellectual disability (ID) affects 1-3% of the population, yet effective therapies remain elusive. Dysregulated lipid metabolism has been implicated in ID, but the underlying mechanisms and translational potential are poorly understood. Here, we identify the lipid-metabolizing enzyme acyl-coenzyme A (CoA) synthetase long-chain family member 4 (Acsl4) as a key regulator of synaptic plasticity, engram cell activation, and cognition, in a developmental stage-dependent manner. Neuron-specific Acsl4 knockout mice, which recapitulate key features of human ID, exhibit disrupted diacylglycerol-protein kinase c (PKC) signaling - a pathway essential for memory formation. Lipidomic and transcriptomic profiling reveals a reduction in diacylglycerol species and downregulation of synapse-related genes. Remarkably, restoring expression of the brain-specific Acsl4_B isoform via AAV-mediated gene therapy during development, or pharmacologically activating PKC with Bryostatin 1 - a clinically tested compound - fully rescues cognitive and synaptic deficits. These findings define the pathogenic mechanism of ACSL4-related ID and uncover a therapeutically actionable lipid signaling pathway, providing a framework for targeted intervention in neurodevelopmental disorders involving lipid dysregulation.
    DOI:  https://doi.org/10.21203/rs.3.rs-7437638/v1
  19. Cell Rep. 2026 May 07. pii: S2211-1247(26)00435-3. [Epub ahead of print]45(5): 117357
      Inborn errors in propionyl-CoA carboxylase cause life-threatening propionic acidemia. To understand the contribution of propionyl-CoA metabolism to cellular and systemic metabolic dysfunction, we generated inducible and tissue-specific Pcca knockout mouse models. The inducible whole-body loss of Pcca results in acute metabolic decompensation like the inborn error. The liver-specific loss of Pcca recapitulates these adverse effects, demonstrating the centrality of the liver to systemic disease. Propionate and pyruvate converge in the TCA cycle as major anaplerotic substrates. Strikingly, the lethality of Pcca knockout (KO) mice is reversed by simultaneously inhibiting pyruvate carboxylase (Pcx). Most metabolites suspected as deleterious in propionic acidemia are exacerbated in liver-specific Pcca;Pcx double KO mice with the exception of methylcitrate, suggesting a role of this metabolite in systemic toxicity. These data clarify relevant toxic biomarkers and suggest that rebalancing hepatic TCA cycle metabolism is critical to mitigate the adverse effects from alternative propionyl-CoA metabolic pathways.
    Keywords:  CP: metabolism; TCA cycle; citrate; fatty acid; inborn error; knockout; liver; metabolism; propionate; propionyl-CoA; propionylation
    DOI:  https://doi.org/10.1016/j.celrep.2026.117357
  20. Neuroscience. 2026 May 04. pii: S0306-4522(26)00306-4. [Epub ahead of print]
      The common marmoset is a key model in translational neuroscience, yet the reliance on anesthesia for neuroimaging introduces significant confounds. To provide a physiological basis for future investigations we characterized cerebral glucose metabolism during naturally awake and isoflurane anesthetized states using [18F]FDG PET. Four adult male marmosets underwent repeated PET/CT sessions in a crossover design, alternating tracer uptake between awake and anesthetized conditions. Following normalization of imaging data to the Marmoset Brain Mapping atlas, standardized uptake values (SUV) and SUV ratios (SUVR) were calculated. Metabolic topology was then assessed by combining non-parametric permutation-based voxel-wise statistical mapping with network-level correlation analysis. We observed that anesthesia induces a fundamental reorganization of metabolic topology rather than a uniform global suppression. Voxel-wise analysis revealed significantly elevated metabolism in auditory, inferior temporal, and prefrontal cortices during the awake state, whereas anesthesia induced a redistribution toward subcortical regions, with preserved activity in the hypothalamus and substantia nigra. Furthermore, network analysis revealed a significant increase in mean cortical correlation strength under anesthesia (awake: r = 0.162; anesthetized: r = 0.209), reflecting paradoxical hypersynchrony driven by the compression of metabolic signal variance. In contrast, subcortical connectivity strength declined (awake: r = 0.291; anesthetized: r = 0.220), indicating that subcortical regulatory centers displayed a disruption of cohesive functional coupling. By systematically defining these state-dependent alterations, our findings offer a physiological reference for distinguishing biological baselines from anesthetic artifacts, thereby reinforcing the translational validity of future marmoset investigations.
    Keywords:  18F-FDG; Brain; Common marmoset; Isoflurane; PET/CT
    DOI:  https://doi.org/10.1016/j.neuroscience.2026.05.003
  21. Brain Behav Immun. 2026 May 01. pii: S0889-1591(26)00538-6. [Epub ahead of print]136 106790
      Dextromethorphan (DXM), a centrally acting non-narcotic antitussive, is subject to abuse worldwide, yet the risks associated with its long-term intake remain unclear. In this study, we examined the behavioral effects of repeated once-daily intraperitoneal administration of DXM at doses of 30 mg/kg and 50 mg/kg for 14 consecutive days in male mice and evaluated the toxic effects and underlying mechanisms in the intestine and brain using exploratory magnetic resonance imaging and physiological and biochemical indicators. The results suggested that DXM administration may attenuate neuronal activity in the prefrontal cortex and hippocampus and was associated with intestinal and brain tissue damage as well as apoptosis. At the high dose, the pro-inflammatory cytokine IL-1β was increased by 30% in both intestinal and brain tissues, whereas the anti-inflammatory cytokine IL-10 was decreased by 15% in the intestine and by 35.7% in the brain. DXM exposure also altered the gut microbiota composition. In parallel, serum lipopolysaccharide (LPS) levels were increased by 1.3-fold, suggesting potential disruption of the intestinal barrier and possible systemic effects via circulation. DXM was associated with alterations in gut microbiota composition, and gut-derived metabolites were correlated with dysregulation of lysophosphatidylcholine (LPC) metabolism in the brain. The abnormal accumulation of LPC was associated with lipid metabolic disturbances, which were in turn correlated with alterations in the brain microenvironment and neuroinflammation. Collectively, these results suggest that long-term DXM exposure may be associated with intestinal injury and alterations in brain metabolism, providing insights into the potential health risks associated with chronic DXM abuse.
    Keywords:  Dextromethorphan; Drug abuse; Metabolic dysregulation; Neuroinflammation
    DOI:  https://doi.org/10.1016/j.bbi.2026.106790
  22. Biomed Pharmacother. 2026 May 01. pii: S0753-3322(26)00509-3. [Epub ahead of print]199 119473
      A growing body of evidence suggests that reduced metabolic activity in astrocytes may compromise their normal supportive role for neurons and trigger pathophysiological pathways that contribute to the progression of Alzheimer's disease (AD). Due to the complexity of AD pathophysiology, it is crucial to study the disease not only within those contexts traditionally viewed from a neuron-centric perspective. In this study, we settled up a new model of AD by exposing primary rat cortical astrocytes to glyceraldehyde (GA), an inhibitor of glycolytic pathway able to induce a significant hypometabolism and recapitulate several AD pathomechanisms. Accordingly, GA-induced hypometabolism produced (a) astrocytosis, as revealed by the increase in GFAP and Glutamine Synthase (GS) immunosignals, (b) mitochondrial dysfunction, detected as reduced ATP level, mitochondrial ROS hyperproduction and Ca2 + dyshomeostasis at both cytosolic and mitochondrial level (c) inflammation, measured as NF-κB activation, TNFα release, AGEs hyperproduction/RAGE hyperexpression and increase in S100β immunosignal, and, finally (d) autophagy impairment, characterized by the p62 and LC3II protein accumulation. By virtue of glutamate ability to stimulate cell metabolism, we examined the effect of the neurotransmitter supplementation on cell damage and those correlated mechanisms in the proposed AD model. Of interest, metabolic, inflammatory and autophagy defects were mitigated when astrocytes were exposed to glutamate as metabolic boosting substrate. The protective effect of glutamate was counteracted by the pharmacological inhibition of astrocytic glutamate transporters, thus highlighting the relevance of glutamate intracellular action. Collectively, these results highlight the importance of considering astrocyte-targeted therapies as potential strategy in AD.
    Keywords:  Alzheimer’s disease; Ca(2+) dysfunction; autophagy impairment; bioenergetics; cortical astrocytes; glutamate; inflammation
    DOI:  https://doi.org/10.1016/j.biopha.2026.119473